↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(AQUILONIUS SM) "

Search: WFRF:(AQUILONIUS SM)

Result 1-10 of 13

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Aquilonius, SM, et al. (author) Introduction 2004 In: PARKINSONISM & RELATED DISORDERS. - : Elsevier BV. - 1353-8020. ; 10:5, s. 257-258 Journal article (other academic/artistic)
2.	Jansson, I, et al. (author) Cytotoxic effects of ALS serum on human cell lines 1995 In: J Neurol Sci. ; 129, s. 138- Journal article (peer-reviewed)
3.	Nilsson, D, et al. (author) Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography 1999 In: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. - 0928-0987. ; 7:3, s. 185-189 Journal article (peer-reviewed)
4.	Nilsson, D, et al. (author) Long-term intraduodenal infusion of a water based levodopa-carbidopadispersion in very advanced Parkinson's disease. 1998 In: Acta Neurol Scand. ; 97, s. 175- Journal article (peer-reviewed)
5.	Nyholm, D, et al. (author) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease 2005 In: Neurology. - 0028-3878 .- 1526-632X. ; 64:2, s. 216-223 Journal article (peer-reviewed)abstract Objectives: To compare daytime intraduodenal levodopa/carbidopa infusion as monotherapy with individually optimized conventional combination therapies in patients with advanced Parkinson disease (PD) for motor fluctuations and quality of life (QoL). Methods: Twenty-four patients with motor fluctuations and dyskinesia were studied in a randomized crossover design to compare individualized conventional treatment and intraduodenal infusion of a levodopa/ carbidopa gel for 3 + 3 weeks. Video scoring of motor function was assessed by blinded assessors on a global Treatment Response Scale from -3 to 0 to +3 (from severe "off" to "on" to "on" with severe dyskinesia). Patient self-assessment of motor performance and QoL was done using an electronic diary. Results: Median percentage of ratings in a functional "on" interval (-1 to +1) was increased from 81 to 100% by infusion therapy (p < 0.01). This improvement was accompanied by a decrease in "off" state (p < 0.01) and no increase in dyskinesia. Median Unified Parkinson's Disease Rating Scale score decreased from 53 to 35 in favor of infusion (p < 0.05). QoL was improved, using the two instruments: Parkinson's Disease Questionnaire-39 and 15D Quality of Life Instrument (p < 0.01). Adverse events were similar for both treatment strategies. Conclusions: Continuous intraduodenal infusion of the levodopa/carbidopa enteral gel as monotherapy is safe and clinically superior to a number of individually optimized combinations of conventional oral and subcutaneous medications in patients with motor fluctuations. Intraduodenal infusion of levodopa offers an important alternative in treating patients with advanced Parkinson disease.
6.	Nyholm, D, et al. (author) Enteral levodopa infusion as monotherapy is superior to conventional oral treatment of advanced Parkinson's disease 2004 In: MOVEMENT DISORDERS. - 0885-3185. ; 19, s. S178-S179 Conference paper (other academic/artistic)
7.	Ramstrom, M, et al. (author) Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry 2004 In: Proteomics. - : Wiley. - 1615-9853. ; 4:12, s. 4010-4018 Journal article (peer-reviewed)
8.	Scott, B, et al. (author) Gender differences in Parkinson's disease symptom profile 2000 In: ACTA NEUROLOGICA SCANDINAVICA. - 0001-6314. ; 102:1, s. 37-43 Journal article (peer-reviewed)abstract Gender symptom differences were studied in 948 subjects with Parkinson's disease (PD) using a questionnaire covering the most common symptoms associated with PD at debut (SP-1) and at present (SP-2). The symptoms most frequently reported by both genders w
9.	Sunden-Cullberg, J, et al. (author) Reversible chorea in primary antiphospholipid syndrome 1998 In: Movement disorders : official journal of the Movement Disorder Society. - 0885-3185. ; 13, s. 147- Journal article (peer-reviewed)
10.	Swartling, C, et al. (author) [Hyperhidrosis--the "silent" handicap] 2011 In: Lakartidningen. - 0023-7205. ; 108:47, s. 2428-32 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 13

Refine your search

Type of publication: journal article (12); conference paper (1)

Type of content: peer-reviewed (11); other academic/artistic (2)

Author/Editor: Aquilonius, SM (13); Tedroff, J (5); Langstrom, B (4); Hartvig, P (3); Askmark, H (3); Nilsson, D (2); show more...; Holmberg, B (2); Nyholm, D. (2); Pedersen, M. (1); Johansson, K (1); Johansson, A (1); Lennernas, H (1); Bergquist, Jonas (1); Brismar, K (1); Walum, E (1); Nystrom, C (1); Fuxe, K (1); Battistin, L (1); Zubarev, R (1); Andersson, Y. (1); Markides, KE (1); Sundin, A (1); Scott, B (1); Fasth, KJ (1); Ekblom, J (1); Hakansson, P (1); Karimi, R (1); Engler, H (1); Ivonin, I (1); Dizdar, N. (1); Jacobsson, G (1); Jansson, I (1); PAALZOW, L (1); Swartling, C (1); Constantinescu, R (1); Westermark, K (1); Hansson, LE (1); HORNFELDT, K (1); Ramstrom, M (1); Dizdar Segrell, Nil, ... (1); Sunden-Cullberg, J (1); Johnels, B (1); Jansson, R. (1); Rosell, K. (1); Rystedt, A. (1); Thuomas, KA (1); Nilsson Remahl, AIM (1); Remahl, LN (1); Borgman, A. (1); Naver, H (1); show less...

University: Karolinska Institutet (9); Uppsala University (5); Linköping University (1)

Language: English (13)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view